Team:Hong Kong HKUST/notebook/mod1

From 2013.igem.org

(Difference between revisions)
Line 397: Line 397:
   <div>
   <div>
       <a href='#' class='head'>Week 3</a>
       <a href='#' class='head'>Week 3</a>
-
       <div class='content' align="left">Content 1
+
       <div class='content' align="left">
 +
<p>&nbsp;</p>
 +
<p><strong>July 15:</strong></p>
 +
<ul>
 +
  <li>Seeded HepG2 cells into 96-well plate for MTT cell viability test and adding FA</li>
 +
  <li>Seeded HepG2 cells into 96-well plate for transfection of PEGFP-N1</li>
 +
</ul>
 +
<p>&nbsp;</p>
 +
<p><strong>July 16:</strong></p>
 +
<ul>
 +
  <li>Transfection of PEGFP-N1 into HepG2 cells</li>
 +
  <li>Passaged HepG2 cells</li>
 +
</ul>
 +
<p>&nbsp;</p>
 +
<p><strong>July 17:</strong></p>
 +
<ul>
 +
  <li>Changed the medium after transfection had been done in 24 hours</li>
 +
  <li>Did MTT assay and getting result (adding FA in the wrong time, cannot be used)</li>
 +
  <li>Made new DMEM</li>
 +
  <li>Changed medium for the cell line</li>
 +
</ul>
 +
<p>&nbsp;</p>
 +
<p><strong>July 18:</strong></p>
 +
<ul>
 +
  <li>Seeded HepG2 cells in 24-well plate for transfection of PEGFP-N1, PCMV/myc/mito/EGFP and PCMY/myc/mito/GFP</li>
 +
  <li>Got polylysine for coating</li>
 +
</ul>
 +
<p>&nbsp;</p>
 +
<p><strong>July 19:</strong></p>
 +
<ul>
 +
  <li>Changed the medium for the HepG2 cell line</li>
 +
  <li>Seeded cells for another MTT assay</li>
 +
  <li>Checked HepG2 cells for transfection: growing slow, 30% confluency, cannot do transfection</li>
 +
  <li>Seeded cells on a 96-well plate for transfection in the coming week</li>
 +
  <li>Passaged HepG2 cells</li>
 +
</ul>
 +
<p>&nbsp;</p>
       </div>
       </div>
   </div>
   </div>
Line 403: Line 439:
   <div>
   <div>
       <a href='#' class='head'>Week 4</a>
       <a href='#' class='head'>Week 4</a>
-
       <div class='content' align="left">Content 1
+
       <div class='content' align="left">
 +
<p>&nbsp;</p>
 +
<p><strong>July 22:</strong></p>
 +
<ul>
 +
  <li>Transfection of PEGFP-N1, PCMV/myc/mito/EGFP and PCMY/myc/mito/GFP on 96-well plate</li>
 +
  <li>Added gradient concentration of sodium palmitate into HepG2 cells for MTT assay</li>
 +
  <li>Coated coverslips with polylysine for HepG2 cell staining and fixation</li>
 +
</ul>
 +
<p>&nbsp;</p>
 +
<p><strong>July 23:</strong></p>
 +
<ul>
 +
  <li>Replaced the medium after transfection of PEGFP-N1, PCMV/myc/mito/EGFP and PCMY/myc/mito/GFP</li>
 +
  <li>Finished MTT assay to get cell viability in different FA concentrations in 24 hours</li>
 +
  <li>Transferredcells containing PEGFP-N1, PCMV/myc/mito/EGFP and PCMY/myc/mito/GFP into 24-well plate with well-coated coverslips in each well</li>
 +
</ul>
 +
<p>&nbsp;</p>
 +
<p><strong>July 24:</strong></p>
 +
<ul>
 +
  <li>Stained mitochondria by Mito-tracker@Red and fixating by formaldehyde of HepG2 cells transfected with PEGFP-N1, PCMV/myc/mito/EGFP and PCMY/myc/mito/GFP in 24-well plate</li>
 +
  <li>Passaged HepG2 cells and changing medium of the cell line</li>
 +
</ul>
 +
<p>&nbsp;</p>
 +
<p><strong>July 25:</strong></p>
 +
<ul>
 +
  <li>Got results for cell staining and fixation: No obvious overlapping pattern between GPF signal and Mito-tracker red.</li>
 +
</ul>
 +
<p>&nbsp;</p>
 +
<p><strong>July 26:</strong></p>
 +
<ul>
 +
  <li>Coated coverslips by polylysine</li>
 +
  <li>Seeded HepG2 cells in one 24-well plate for transfection of PEGFP-N1, PCMV/myc/mito/EGFP and PCMY/myc/mito/GFP </li>
 +
  <li>Seeded HepG2 cells on two 96-well plate, for transfection of FABP and MTT assay in 48 hours</li>
 +
</ul>
 +
<p>&nbsp;</p>
       </div>
       </div>
   </div>  
   </div>  
Line 409: Line 478:
   <div>
   <div>
       <a href='#' class='head'>Week 5</a>
       <a href='#' class='head'>Week 5</a>
-
       <div class='content' align="left">Content 1
+
       <div class='content' align="left">
 +
<p>&nbsp;</p>
 +
<p><strong>July 29:</strong></p>
 +
<ul>
 +
  <li>Transfection of FABP with PEGFP-N1 as control</li>
 +
  <li>Transfection of PEGFP-N1, PCMV/myc/mito/EGFP and PCMY/myc/mito/GFP in 24-well plate with well-coated coverslips</li>
 +
  <li>Added gradient concentration form 0.1mM to 1.2mM of FA into the plate for MTT assay</li>
 +
</ul>
 +
<p>&nbsp;</p>
 +
<p><strong>July 30:</strong></p>
 +
<ul>
 +
  <li>Changed medium after transfection of PEGFP-N1 and FABP and seeing the results: Both PEGFP-N1 and FABP did not show GFP signals</li>
 +
  <li>Changed medium after transfection of PEGFP-N1, PCMV/myc/mito/EGFP and PCMY/myc/mito/GFP</li>
 +
  <li>Did staining and fixation of the coverslips and seeing the results: No obvious overlapping patterns of GFP signals and Mito-tracker red</li>
 +
  <li>Passaged HepG2 cells</li>
 +
</ul>
 +
<p>&nbsp;</p>
       </div>
       </div>
   </div>
   </div>

Revision as of 15:51, 19 September 2013








June 2013

Week 4

 

June 25:

  • Prepared DMEM in TC room
  • Added FBS (Serum) & Antibiotics into DMEM

 

June 27:

  • Designed the experiment for testing FA concentration by GCMS

 

June 28:

  • HepG2 cell culturing (first generation)

July 2013

Week 1

 

July 2:

  • HepG2 cell passaging
  • Made sodium palmitate from powder to solution by 50% Ethanol

 

July 3:

  • Used GCMS to quantify the FA in the medium

 

July 4:

  • Passaged HepG2 cells
  • Changed medium for cell line
  • Searched for information of MTT assay and Transfection by lipofectamine
  • Got GCMS results for the last day: Not accurate/usable

 

July 5:

  • Repeated GCMS test again testing FA in medium and we made
  • Got the result of GCMS: Not accurate/usable

 

Week 2

 

July 8:

  • Passaged HepG2 cells
  • Used some HepG2 cells to extract genomic DNA

 

July 9:

  • Another try of GCMS with a gradient concentration of FA
  • Got the result of GCMS: Not match with the concentration we made

 

July 10:

  • Repeated GCMS: No accurate results
  • Changed Medium for the cell line
  • Checked lipofectamine protocol

 

July 11:

  • GCMS again for the same sodium palmitate we made: Not accurate results
  • Passaged HepG2 cell line

 

July 12:

  • Prepared reagents for MTT assay for cell viability test, protocols checked
  • Changed the medium of the cell line

 

Week 3

 

July 15:

  • Seeded HepG2 cells into 96-well plate for MTT cell viability test and adding FA
  • Seeded HepG2 cells into 96-well plate for transfection of PEGFP-N1

 

July 16:

  • Transfection of PEGFP-N1 into HepG2 cells
  • Passaged HepG2 cells

 

July 17:

  • Changed the medium after transfection had been done in 24 hours
  • Did MTT assay and getting result (adding FA in the wrong time, cannot be used)
  • Made new DMEM
  • Changed medium for the cell line

 

July 18:

  • Seeded HepG2 cells in 24-well plate for transfection of PEGFP-N1, PCMV/myc/mito/EGFP and PCMY/myc/mito/GFP
  • Got polylysine for coating

 

July 19:

  • Changed the medium for the HepG2 cell line
  • Seeded cells for another MTT assay
  • Checked HepG2 cells for transfection: growing slow, 30% confluency, cannot do transfection
  • Seeded cells on a 96-well plate for transfection in the coming week
  • Passaged HepG2 cells

 

Week 4

 

July 22:

  • Transfection of PEGFP-N1, PCMV/myc/mito/EGFP and PCMY/myc/mito/GFP on 96-well plate
  • Added gradient concentration of sodium palmitate into HepG2 cells for MTT assay
  • Coated coverslips with polylysine for HepG2 cell staining and fixation

 

July 23:

  • Replaced the medium after transfection of PEGFP-N1, PCMV/myc/mito/EGFP and PCMY/myc/mito/GFP
  • Finished MTT assay to get cell viability in different FA concentrations in 24 hours
  • Transferredcells containing PEGFP-N1, PCMV/myc/mito/EGFP and PCMY/myc/mito/GFP into 24-well plate with well-coated coverslips in each well

 

July 24:

  • Stained mitochondria by Mito-tracker@Red and fixating by formaldehyde of HepG2 cells transfected with PEGFP-N1, PCMV/myc/mito/EGFP and PCMY/myc/mito/GFP in 24-well plate
  • Passaged HepG2 cells and changing medium of the cell line

 

July 25:

  • Got results for cell staining and fixation: No obvious overlapping pattern between GPF signal and Mito-tracker red.

 

July 26:

  • Coated coverslips by polylysine
  • Seeded HepG2 cells in one 24-well plate for transfection of PEGFP-N1, PCMV/myc/mito/EGFP and PCMY/myc/mito/GFP
  • Seeded HepG2 cells on two 96-well plate, for transfection of FABP and MTT assay in 48 hours

 

Week 5

 

July 29:

  • Transfection of FABP with PEGFP-N1 as control
  • Transfection of PEGFP-N1, PCMV/myc/mito/EGFP and PCMY/myc/mito/GFP in 24-well plate with well-coated coverslips
  • Added gradient concentration form 0.1mM to 1.2mM of FA into the plate for MTT assay

 

July 30:

  • Changed medium after transfection of PEGFP-N1 and FABP and seeing the results: Both PEGFP-N1 and FABP did not show GFP signals
  • Changed medium after transfection of PEGFP-N1, PCMV/myc/mito/EGFP and PCMY/myc/mito/GFP
  • Did staining and fixation of the coverslips and seeing the results: No obvious overlapping patterns of GFP signals and Mito-tracker red
  • Passaged HepG2 cells

 

August 2013

Week 1
Content 1
Week 2
Content 1
Week 3
Content 1
Week 4
Content 1

September 2013

Week 1
Content 1
Week 2
Content 1
Week 3
Content 1
Week 4
Content 1
Week 5
Content 1